AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
Authors
Keywords
-
Journal
Antioxidants
Volume 10, Issue 12, Pages 1994
Publisher
MDPI AG
Online
2021-12-15
DOI
10.3390/antiox10121994
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
- (2021) Elena Dozio et al. Biomedicines
- Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
- (2021) Elena Dozio et al. Journal of Clinical Medicine
- The association of skin autofluorescence with cardiovascular events and all-cause mortality in persons with chronic kidney disease stage 3: A prospective cohort study
- (2020) Adam Shardlow et al. PLOS MEDICINE
- Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
- (2020) Junko Yabuuchi et al. Scientific Reports
- Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
- (2020) Elena Dozio et al. Biomedicines
- Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD
- (2019) Simone Vettoretti et al. Nutrients
- Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
- (2018) Ian H. de Boer et al. DIABETES CARE
- The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)
- (2018) Tae Nyun Kim et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Advanced glycation end products in the pathogenesis of chronic kidney disease
- (2018) Naila Rabbani et al. KIDNEY INTERNATIONAL
- Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
- (2018) Jesus Calviño et al. PLoS One
- Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
- (2018) Elena Dozio et al. MEDIATORS OF INFLAMMATION
- Methylglyoxal as a Prognostic Factor in Patients with Chronic Kidney Disease
- (2018) Yuta Tezuka et al. NEPHROLOGY
- Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
- (2017) Tomasz W. Kamiński et al. BMC Nephrology
- Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
- (2017) Alexis Guerin-Dubourg et al. Biomed Research International
- Oxidant Mechanisms in Renal Injury and Disease
- (2016) Brian B. Ratliff et al. ANTIOXIDANTS & REDOX SIGNALING
- Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism
- (2016) Gudrun Caspar-Bell et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease
- (2016) Alejandra Guillermina Miranda-Díaz et al. Journal of Diabetes Research
- Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study
- (2015) Mariana Lazo et al. AMERICAN HEART JOURNAL
- Uremic Toxicity of Advanced Glycation End Products in CKD
- (2015) A. E. M. Stinghen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- S100/Calgranulin-Mediated Inflammation Accelerates Left Ventricular Hypertrophy and Aortic Valve Sclerosis in Chronic Kidney Disease in a Receptor for Advanced Glycation End Products-Dependent Manner
- (2014) L. Yan et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression
- (2014) Marita Liebisch et al. KIDNEY INTERNATIONAL
- Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
- (2014) Casey M. Rebholz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
- (2013) Keiko Fujisawa et al. ATHEROSCLEROSIS
- Skin Autofluorescence Is Associated with the Progression of Chronic Kidney Disease: A Prospective Observational Study
- (2013) Kenichi Tanaka et al. PLoS One
- Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
- (2011) Jwa-Kyung Kim et al. ATHEROSCLEROSIS
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
- (2010) Johanna W.M. Nin et al. DIABETES
- Reduced soluble receptor for advanced glycation end-products in COPD
- (2010) D. J. Smith et al. EUROPEAN RESPIRATORY JOURNAL
- RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
- (2008) Alexey Aleshin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Olmesartan Ameliorates Progressive Glomerular Injury in Subtotal Nephrectomized Rats through Suppression of Superoxide Production
- (2008) Sohachi FUJIMOTO et al. HYPERTENSION RESEARCH
- Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (−/−) mice and improved by combined administration of L-arginine and antioxidants
- (2008) MONICA G ARELLANO MENDOZA et al. NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More